161 related articles for article (PubMed ID: 28315311)
1. The effects of CRF and urocortins on the sociability of mice.
Bagosi Z; Karasz G; Czébely-Lénárt A; Csabafi K; Jászberényi M; Telegdy G
Brain Res; 2017 May; 1663():114-122. PubMed ID: 28315311
[TBL] [Abstract][Full Text] [Related]
2. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.
Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z
Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861
[TBL] [Abstract][Full Text] [Related]
3. The effects of CRF and urocortins on the preference for social novelty of mice.
Bagosi Z; Czébely-Lénárt A; Karasz G; Csabafi K; Jászberényi M; Telegdy G
Behav Brain Res; 2017 May; 324():146-154. PubMed ID: 28189757
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
[TBL] [Abstract][Full Text] [Related]
5. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Jászberényi M; Telegdy G
Neurochem Int; 2012 Mar; 60(4):350-4. PubMed ID: 22306347
[TBL] [Abstract][Full Text] [Related]
6. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular responses to microinjections of urocortins into the NTS: role of inotropic glutamate receptors.
Nakamura T; Sapru HN
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H2022-9. PubMed ID: 19395554
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1.
Tsatsanis C; Androulidaki A; Alissafi T; Charalampopoulos I; Dermitzaki E; Roger T; Gravanis A; Margioris AN
J Immunol; 2006 Feb; 176(3):1869-77. PubMed ID: 16424218
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
[TBL] [Abstract][Full Text] [Related]
10. The peripheral corticotropin releasing factor family's role in vasculitis.
Zhu C; Li S
Vascul Pharmacol; 2024 Mar; 154():107275. PubMed ID: 38184094
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of gonadotropin-releasing hormone by corticotropin-releasing factor family peptides in hypothalamic N39 cells.
Kageyama K; Hasegawa G; Akimoto K; Yamagata S; Tamasawa N; Suda T
Peptides; 2012 Jan; 33(1):149-55. PubMed ID: 22138165
[TBL] [Abstract][Full Text] [Related]
12. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.
Tasma Z; Wills P; Hay DL; Walker CS
Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807
[TBL] [Abstract][Full Text] [Related]
13. Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk.
Mahajan S; Liao M; Barkan P; Takahashi K; Bhargava A
Peptides; 2014 Apr; 54():58-66. PubMed ID: 24462512
[TBL] [Abstract][Full Text] [Related]
14. Effects of stress-related peptides on chloride secretion in the mouse proximal colon.
Liu S; Karo A; Agterberg S; Hua H; Bhargava A
Neurogastroenterol Motil; 2021 Apr; 33(4):e14021. PubMed ID: 33118282
[TBL] [Abstract][Full Text] [Related]
15. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders.
Fukuda T; Takahashi K; Suzuki T; Saruta M; Watanabe M; Nakata T; Sasano H
J Clin Endocrinol Metab; 2005 Aug; 90(8):4671-8. PubMed ID: 15914529
[TBL] [Abstract][Full Text] [Related]
16. Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: effect of vasoactive intestinal peptide.
Pérez-García S; Juarranz Y; Carrión M; Gutiérrez-Cañas I; Margioris A; Pablos JL; Tsatsanis C; Gomariz RP
J Cell Physiol; 2011 Dec; 226(12):3261-9. PubMed ID: 21360527
[TBL] [Abstract][Full Text] [Related]
17. Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes.
Dermitzaki E; Liapakis G; Androulidaki A; Venihaki M; Melissas J; Tsatsanis C; Margioris AN
PLoS One; 2014; 9(5):e97060. PubMed ID: 24835211
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA
J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
